These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36972232)

  • 1. Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
    McLean Diaz P; Vannier A; Joshi AD; Mahle RE; Przybyszewski EM; Corey K; Chung RT; Luther J; Goodman RP; Schaefer EAK
    Clin Transl Gastroenterol; 2023 Jun; 14(6):e00585. PubMed ID: 36972232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
    Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H
    Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis.
    Hanouneh IA; Zein NN; Cikach F; Dababneh L; Grove D; Alkhouri N; Lopez R; Dweik RA
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):516-23. PubMed ID: 24036050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
    Trépo E; Goossens N; Fujiwara N; Song WM; Colaprico A; Marot A; Spahr L; Demetter P; Sempoux C; Im GY; Saldarriaga J; Gustot T; Devière J; Thung SN; Minsart C; Sersté T; Bontempi G; Abdelrahman K; Henrion J; Degré D; Lucidi V; Rubbia-Brandt L; Nair VD; Moreno C; Deltenre P; Hoshida Y; Franchimont D
    Gastroenterology; 2018 Mar; 154(4):965-975. PubMed ID: 29158192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 drives human and mouse alcohol-related liver disease.
    Effenberger M; Widjaja AA; Grabherr F; Schaefer B; Grander C; Mayr L; Schwaerzler J; Enrich B; Moser P; Fink J; Pedrini A; Jaschke N; Kirchmair A; Pfister A; Hausmann B; Bale R; Putzer D; Zoller H; Schafer S; Pjevac P; Trajanoski Z; Oberhuber G; Adolph T; Cook S; Tilg H
    Gut; 2023 Jan; 72(1):168-179. PubMed ID: 35365572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    Atkinson SR; Grove JI; Liebig S; Astbury S; Vergis N; Goldin R; Quaglia A; Bantel H; Guha IN; Thursz MR; Newcombe P; Strnad P; Aithal GP
    Am J Gastroenterol; 2020 Nov; 115(11):1857-1868. PubMed ID: 33156105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abstinence from alcohol and alcohol rehabilitation therapy in alcoholic liver disease: a population-based study.
    Björnsson ES; Hauksson K; Sigurdardottir R; Arnardottir M; Agustsson AS; Lund SH; Kalaitzakis E
    Scand J Gastroenterol; 2020 Apr; 55(4):472-478. PubMed ID: 32233877
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.
    Gala KS; Vatsalya V
    Cells; 2020 Feb; 9(3):. PubMed ID: 32106390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin 8 and 12 levels predict severity and mortality in patients with alcoholic hepatitis.
    Patel OP; Noor MT; Kumar R; Thakur BS
    Indian J Gastroenterol; 2015 May; 34(3):209-15. PubMed ID: 26108651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Panchal SA; Kaplan DE; Goldberg DS; Mahmud N
    Dig Dis Sci; 2022 Sep; 67(9):4395-4402. PubMed ID: 35022905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.
    Lee BP; Samur S; Dalgic OO; Bethea ED; Lucey MR; Weinberg E; Hsu C; Rinella ME; Im GY; Fix OK; Therapondos G; Han H; Victor DW; Voigt MD; Eswaran S; Terrault NA; Chhatwal J
    Gastroenterology; 2019 Aug; 157(2):472-480.e5. PubMed ID: 30998988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
    Sandahl TD; Støy SH; Laursen TL; Rødgaard-Hansen S; Møller HJ; Møller S; Vilstrup H; Grønbæk H
    PLoS One; 2017; 12(12):e0189345. PubMed ID: 29236785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Virome in Patients With Alcoholic Hepatitis.
    Jiang L; Lang S; Duan Y; Zhang X; Gao B; Chopyk J; Schwanemann LK; Ventura-Cots M; Bataller R; Bosques-Padilla F; Verna EC; Abraldes JG; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross DL; Ho SB; Louvet A; Lucey MR; Mathurin P; Garcia-Tsao G; Kisseleva T; Brenner DA; Tu XM; Stärkel P; Pride D; Fouts DE; Schnabl B
    Hepatology; 2020 Dec; 72(6):2182-2196. PubMed ID: 32654263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis.
    Lee DH; Choi YI; Bae JM; Chang MS; Joo SK; Jung YJ; Lee KL; Kim BG; Kim W
    Gut Liver; 2020 Sep; 14(5):636-643. PubMed ID: 32457277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
    Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
    Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery and outcomes of patients denied early liver transplantation for severe alcohol-associated hepatitis.
    Musto J; Stanfield D; Ley D; Lucey MR; Eickhoff J; Rice JP
    Hepatology; 2022 Jan; 75(1):104-114. PubMed ID: 34387875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an Integrated Transplantation Mental Health Program on Alcohol Relapse After Liver Transplantation for Severe Alcoholic Hepatitis: A Single-Center Prospective Study.
    Zanowski SC; Price JS; Selim MA; Schumann V; Durazo F; Hong JC
    Transplant Proc; 2022 Dec; 54(10):2627-2633. PubMed ID: 36411097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis.
    Hardesty J; Day L; Warner J; Warner D; Gritsenko M; Asghar A; Stolz A; Morgan T; McClain C; Jacobs J; Kirpich I
    Am J Pathol; 2022 Jul; 192(7):1066-1082. PubMed ID: 35490715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis.
    Blaya D; Rubio-Tomás T; Rodrigo-Torres D; Lozano J; Coll M; Argemi J; Altamirano J; Affò S; Morales-Ibanez O; Gratacós-Ginès J; Pose E; Tanguy M; Issoufaly T; Rautou PE; Bataller R; Caballería J; Sancho-Bru P
    Hepatol Int; 2021 Aug; 15(4):1006-1017. PubMed ID: 33954832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.